SEC FORM 4
$12,994.56
Akari Therapeutics Plc (AKTX)
Acquisition (code A) of 1,728 shares at $7.52 per share.
Reporting Person Farag Kameel D. · Officer Title Interim CFO · Transaction Code A
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001493152-26-039246 · filed 2026-08-19 · View filing →